Researchers showed that the SARS-CoV-2 envelope protein alone is able to cause acute respiratory distress syndrome-like damages in vitro and in vivo.
[Science Immunology]
6445218
{6445218:NJGPG8KK}
apa
50
1
163370
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-7654122f77a5abf123622044d8ffa611%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22NJGPG8KK%22%2C%22library%22%3A%7B%22id%22%3A6445218%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Goel%20et%20al.%22%2C%22parsedDate%22%3A%222021-04-15%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EGoel%2C%20R.%20R.%2C%20Apostolidis%2C%20S.%20A.%2C%20Painter%2C%20M.%20M.%2C%20Mathew%2C%20D.%2C%20Pattekar%2C%20A.%2C%20Kuthuru%2C%20O.%2C%20Gouma%2C%20S.%2C%20Hicks%2C%20P.%2C%20Meng%2C%20W.%2C%20Rosenfeld%2C%20A.%20M.%2C%20Dysinger%2C%20S.%2C%20Lundgreen%2C%20K.%20A.%2C%20Kuri-Cervantes%2C%20L.%2C%20Adamski%2C%20S.%2C%20Hicks%2C%20A.%2C%20Korte%2C%20S.%2C%20Oldridge%2C%20D.%20A.%2C%20Baxter%2C%20A.%20E.%2C%20Giles%2C%20J.%20R.%2C%20%26%23x2026%3B%20Wherry%2C%20E.%20J.%20%282021%29.%20Distinct%20antibody%20and%20memory%20B%20cell%20responses%20in%20SARS-CoV-2%20na%26%23xEF%3Bve%20and%20recovered%20individuals%20following%20mRNA%20vaccination.%20%3Ci%3EScience%20Immunology%3C%5C%2Fi%3E%2C%20%3Ci%3E6%3C%5C%2Fi%3E%2858%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1126%5C%2Fsciimmunol.abi6950%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1126%5C%2Fsciimmunol.abi6950%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445218%26amp%3Bitem_key%3DNJGPG8KK%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Distinct%20antibody%20and%20memory%20B%20cell%20responses%20in%20SARS-CoV-2%20na%5Cu00efve%20and%20recovered%20individuals%20following%20mRNA%20vaccination%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rishi%20R.%22%2C%22lastName%22%3A%22Goel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sokratis%20A.%22%2C%22lastName%22%3A%22Apostolidis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20M.%22%2C%22lastName%22%3A%22Painter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Divij%22%2C%22lastName%22%3A%22Mathew%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajinkya%22%2C%22lastName%22%3A%22Pattekar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oliva%22%2C%22lastName%22%3A%22Kuthuru%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sigrid%22%2C%22lastName%22%3A%22Gouma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philip%22%2C%22lastName%22%3A%22Hicks%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenzhao%22%2C%22lastName%22%3A%22Meng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aaron%20M.%22%2C%22lastName%22%3A%22Rosenfeld%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Dysinger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kendall%20A.%22%2C%22lastName%22%3A%22Lundgreen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leticia%22%2C%22lastName%22%3A%22Kuri-Cervantes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sharon%22%2C%22lastName%22%3A%22Adamski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%22%2C%22lastName%22%3A%22Hicks%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%22%2C%22lastName%22%3A%22Korte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Derek%20A.%22%2C%22lastName%22%3A%22Oldridge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%20E.%22%2C%22lastName%22%3A%22Baxter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Josephine%20R.%22%2C%22lastName%22%3A%22Giles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Madison%20E.%22%2C%22lastName%22%3A%22Weirick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20M.%22%2C%22lastName%22%3A%22McAllister%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeanette%22%2C%22lastName%22%3A%22Dougherty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sherea%22%2C%22lastName%22%3A%22Long%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kurt%22%2C%22lastName%22%3A%22D%5Cu2019Andrea%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacob%20T.%22%2C%22lastName%22%3A%22Hamilton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20R.%22%2C%22lastName%22%3A%22Betts%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eline%20T.%20Luning%22%2C%22lastName%22%3A%22Prak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%22%2C%22lastName%22%3A%22Bates%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%20E.%22%2C%22lastName%22%3A%22Hensley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Allison%20R.%22%2C%22lastName%22%3A%22Greenplate%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20John%22%2C%22lastName%22%3A%22Wherry%22%7D%5D%2C%22abstractNote%22%3A%22Novel%20mRNA%20vaccines%20for%20SARS-CoV-2%20have%20been%20authorized%20for%20emergency%20use.%20Despite%20their%20efficacy%20in%20clinical%20trials%2C%20data%20on%20mRNA%20vaccine-induced%20immune%20responses%20are%20mostly%20limited%20to%20serological%20analyses.%20Here%2C%20we%20interrogated%20antibody%20and%20antigen-specific%20memory%20B%20cells%20over%20time%20in%2033%20SARS-CoV-2%20na%5Cu00efve%20and%2011%20SARS-CoV-2%20recovered%20subjects.%20SARS-CoV-2%20na%5Cu00efve%20individuals%20required%20both%20vaccine%20doses%20for%20optimal%20increases%20in%20antibodies%2C%20particularly%20for%20neutralizing%20titers%20against%20the%20B.1.351%20variant.%20Memory%20B%20cells%20specific%20for%20full-length%20spike%20protein%20and%20the%20spike%20receptor%20binding%20domain%20%28RBD%29%20were%20also%20efficiently%20primed%20by%20mRNA%20vaccination%20and%20detectable%20in%20all%20SARS-CoV-2%20naive%20subjects%20after%20the%20second%20vaccine%20dose%2C%20though%20the%20memory%20B%20cell%20response%20declined%20slightly%20with%20age.%20In%20SARS-CoV-2%20recovered%20individuals%2C%20antibody%20and%20memory%20B%20cell%20responses%20were%20significantly%20boosted%20after%20the%20first%20vaccine%20dose%3B%20however%2C%20there%20was%20no%20increase%20in%20circulating%20antibodies%2C%20neutralizing%20titers%2C%20or%20antigen-specific%20memory%20B%20cells%20after%20the%20second%20dose.%20This%20robust%20boosting%20after%20the%20first%20vaccine%20dose%20strongly%20correlated%20with%20levels%20of%20pre-existing%20memory%20B%20cells%20in%20recovered%20individuals%2C%20identifying%20a%20key%20role%20for%20memory%20B%20cells%20in%20mounting%20recall%20responses%20to%20SARS-CoV-2%20antigens.%20Together%2C%20our%20data%20demonstrated%20robust%20serological%20and%20cellular%20priming%20by%20mRNA%20vaccines%20and%20revealed%20distinct%20responses%20based%20on%20prior%20SARS-CoV-2%20exposure%2C%20whereby%20COVID-19%20recovered%20subjects%20may%20only%20require%20a%20single%20vaccine%20dose%20to%20achieve%20peak%20antibody%20and%20memory%20B%20cell%20responses.%20These%20findings%20also%20highlight%20the%20utility%20of%20defining%20cellular%20responses%20in%20addition%20to%20serologies%20and%20may%20inform%20SARS-CoV-2%20vaccine%20distribution%20in%20a%20resource-limited%20setting.%5CnKey%20differences%20in%20both%20antibody%20and%20memory%20B%20cell%20responses%20to%20mRNA%20vaccination%20were%20identified%20based%20on%20prior%20SARS-CoV-2%20exposure.%5CnKey%20differences%20in%20both%20antibody%20and%20memory%20B%20cell%20responses%20to%20mRNA%20vaccination%20were%20identified%20based%20on%20prior%20SARS-CoV-2%20exposure.%22%2C%22date%22%3A%222021%5C%2F04%5C%2F15%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1126%5C%2Fsciimmunol.abi6950%22%2C%22ISSN%22%3A%222470-9468%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fimmunology.sciencemag.org%5C%2Fcontent%5C%2F6%5C%2F58%5C%2Feabi6950%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-06-14T18%3A09%3A10Z%22%7D%7D%5D%7D
Goel, R. R., Apostolidis, S. A., Painter, M. M., Mathew, D., Pattekar, A., Kuthuru, O., Gouma, S., Hicks, P., Meng, W., Rosenfeld, A. M., Dysinger, S., Lundgreen, K. A., Kuri-Cervantes, L., Adamski, S., Hicks, A., Korte, S., Oldridge, D. A., Baxter, A. E., Giles, J. R., … Wherry, E. J. (2021). Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination. Science Immunology, 6(58). https://doi.org/10.1126/sciimmunol.abi6950 Cite
